Evidence map›Paper›PMID 41461871›Full record

ArticleScientific reports2025

A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East.

Ahmed A Amer, Hashem Altabbaa, Mohamed Sh Ramadan, Hamza A Abdul-Hafez, Hanaa S Said, Misha Khan, Mohammed Musaed Al-Jabri, Dana Jihad Haj-Salim, Qusai Razzouk, Mohamed A S Amer and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmed A AmerDepartment of Obstetrics and Gynecology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Hashem AltabbaaAlexandria University, Alexandria, Egypt.
Mohamed Sh RamadanDepartment of Obstetrics and Gynecology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Hamza A Abdul-HafezDepartment of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. hamzaakrm12@gmail.com.ORCID http://orcid.org/0009-0003-6089-240X
Hanaa S SaidDepartment of Family Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID http://orcid.org/0000-0002-2760-4002
Misha KhanDepartment of Medicine and Surgery, Liaquat National Hospital and Medical College Address: National Stadium Road, Karachi, 74800, Pakistan.ORCID http://orcid.org/0000-0002-3681-1820
Mohammed Musaed Al-JabriAssistant Professor Critical Care Nursing, Nursing Department, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Wadi Addawasir, Saudi Arabia.ORCID http://orcid.org/0000-0003-1059-3236
Dana Jihad Haj-SalimFaculty of Medicine, Mutah University, Mutah, Jordan.
Qusai RazzoukFaculty of Medicine, University of Aleppo, Aleppo, Syria.ORCID http://orcid.org/0000-0002-9540-1100
Mohamed A S AmerFaculty of Medicine, Menoufia University, Menoufia, Egypt.
Samar A AmerDepartment of Public Health and Community Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Dr_samar11@yahoo.com.
Data Collector Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus is the most common viral sexually transmitted infection worldwide and affects individuals of all ages and both sexes. It is also the most preventable cause of cervical cancer. The World Health Organization’s Cervical Cancer Elimination Strategy (2030 targets) aims for 90% of girls to receive the Human papillomavirus vaccine by age 15, 70% of women to be screened by ages 35–45, and 90% of cervical-cancer cases to be appropriately treated. To determine cervical-cancer–related risk factors and knowledge levels, and to assess Human papillomavirus -related knowledge and attitudes toward vaccination. The survey also examined general adult vaccination behaviors—including measles, influenza, coronavirus, respiratory syncytial virus, and shingles vaccines—among adults. A cross-sectional study was conducted among 1,174 randomly selected adults from Egypt, Syria, Jordan, and Yemen between March and May 2025, using a validated Arabic self-administered questionnaire. Most participants were female (635, 54.2%), university-educated or higher (699, 59.6%), and living in urban areas (796, 67.9%). Regarding risk factors, 489 (41.7%) were smokers, 94 (8.0%) reported genital laser hair removal, 84 (7.2%) had oral or other herpes lesions, and 81 (6.9%) had a family history of reproductive-system cancer. Overall, 626 (53.4%) had poor Human papillomavirus knowledge and 779 (66.5%) had poor cervical-cancer knowledge. Only 60 (9.5%) had ever undergone cervical-cancer screening, and 23 (2.0%) had received at least one Human papillomavirus -vaccine dose. Reported adverse events included allergic reactions (13, 6.8%) and dizziness or fainting (13, 56.5%). Approximately 578 (49.3%) were unaware of the Human papillomavirus vaccine, while 976 (83.3%) had not received—and did not intend to receive—the vaccine, citing lack of information, perceived low risk, adherence to preventive measures, or vaccine unavailability. Most participants demonstrated poor overall knowledge of Human papillomavirus and cervical cancer. Several demographic determinants significantly influenced knowledge and attitudes toward vaccination. Comprehensive health-education initiatives are urgently needed to enhance awareness and progress toward the World Health Organization 2030 elimination targets.

Indexed as

Health Knowledge, Attitudes, PracticeHuman Papillomavirus VirusesPapillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsVaccinationAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedMiddle EastRisk FactorsSurveys and QuestionnairesYoung AdultPapillomavirus VaccinesCervical cancerHuman papillomavirusHuman papillomavirus vaccineKnowledgeVaccination attitudes examination

Identifiers

PMID41461871
PMCPMC12789111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.